Nasal Decongestants - Administration & dosage
Research News and Information

Tuesday, November 24, 2009

Allergic rhinitis: background, symptoms, diagnosis and treatment options.

30 Jul 2009 This one-part unit outlines the symptoms, diagnosis and various treatment options for allergic rhinitis. It also highlights nurses' roles in the management of this common ... Read more...

Nasal congestion index: A measure for nasal obstruction.

30 Jul 2009 OBJECTIVES: The relationship between congestion of the nasal mucosa and subjective nasal obstruction remains poorly defined. Applying the novel Nasal Congestion Index (NCI), we compared subjective nasal obstruction with objective measures for ... Read more...

Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure.

29 Jun 2009 BACKGROUND: No standardized medical therapy for chronic rhinosinusitis (CRS) is universally accepted. Success of medical therapy is reportedly 50% to 88%, but studies differ in inclusion criteria, medications, duration of therapy, and defining ... Read more...

Latest indexed articles for 'Nasal Decongestants - Administration & dosage'

These are the very latest articles for this heading:

• Over-the-counter medications: Zicam nasal products may cause loss of sense of smell... 30 Aug 2009
• Allergic rhinitis: background, symptoms, diagnosis and treatment options. 30 Jul 2009
• Nasal congestion index: A measure for nasal obstruction. 30 Jul 2009
• Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure. 29 Jun 2009
• [Pollen allergy and pregnancy. A literature review of anti-allergic agents shows no increased risk of fetal injuries] 30 May 2009
• Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. 30 May 2009
• Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections. 29 Apr 2009
• Influence of the ageing phenomenon on the low-frequency electrical impedance behavior of naphazoline hydrochloride solutions and paracetamol syrup. 29 Apr 2009
• [Sinusitis] 2 Feb 2009
• The common cold. 30 Jan 2009
• A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis. 30 Jan 2009
• Intranasal lidocaine plus naphazoline nitrate improves surgical conditions and perioperative analgesia in septorhinoplasty surgery. 5 Jan 2009
• Misuse of over-the-counter cough or cold medications among adolescents: prevalence and correlates in a national sample. 2 Jan 2009
• [The specific features of therapy for allergic rhinitis in children] 30 Dec 2008
• [The use of sinupret in the combined treatment of acute otitis media in children] 30 Dec 2008
• Central serous chorioretinopathy after dacryocystorhinostomy operation on the same side. 30 Dec 2008
• Diagnosis and management of nasal congestion: the role of intranasal corticosteroids. 30 Dec 2008
• Rhinitis medicamentosa: what an otolaryngologist needs to know. 17 Dec 2008
• Misuse of xylometazoline nasal drops by inhalation. 29 Nov 2008
• Cotton pledget method for nasal decongestive anesthesia prior to transnasal endoscopy. 29 Nov 2008

See a longer list of these articles.

Technical information about 'Nasal Decongestants'

Definition: Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

Registry Number: 0

Descriptor UI: D014663

Alternative terms: Nasal Decongestants; Decongestants, Nasal; Decongestants; Vasoconstrictor Agents, Nasal; Agents, Nasal Vasoconstrictor; Nasal Vasoconstrictor Agents; Vasoconstrictors, Nasal; Nasal Vasoconstrictors;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.411.793.610; D27.505.954.796.560;

History Note: 96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95

Technical Notes: Nasal Decongestants - do not use entry term VASOCONSTRICTOR AGENTS, NASAL for the nasal administration of systemic vasoconstrictor agents; use instead the specific vasoconstrictor agent / admin + ADMINISTRATION, INTRANASAL